Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...

Management raised fiscal 2025 EPS guidance to $7.85-$8, a $0.10 increase at the midpoint, reflecting strong Pharma performance and contributions from recent acquisitions. The company expects Q3 to be ...

Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its Pharmaceuticals segment.

Cardinal Health has reported second quarter revenue for its “other” businesses, which includes at-Home Solutions, increased 13% to $1.3 billion.

Cardinal Health's pharmaceutical and specialty solutions segment profit increased 7% to $531 million in the second quarter.

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

its direct-to-consumer virtual mental health segment. Chronic care management is going to continue to be an important growth driver for Teladoc, Mala Murthy, chief financial officer, said Monday.

Headquartered in Dublin, OH, Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting ...

Join the dean of the Johns Hopkins School of Education at the Bloomberg School of Public Health to hear authors of the recently published book Creating Safe, Healthy, and Inclusive Schools: Challenges ...

The naval nuclear propulsion market is witnessing significant ... along with an assessment of potential drivers or constraints that may influence the market’s trajectory. These predictions ...

That approach came through prominently as San Diego Cardinal Robert McElroy made his ... with a way for Catholic organizations to cover the health insurance of domestic partners, without ...